HC Wainwright set a $12.00 price objective on Myomo (NYSEAMERICAN:MYO) in a research note issued to investors on Thursday. The firm currently has a buy rating on the stock.

Shares of Myomo (MYO) opened at $4.20 on Thursday. Myomo has a 1 year low of $2.07 and a 1 year high of $23.20. The company has a market cap of $25.96 and a P/E ratio of -0.78.

How to Become a New Pot Stock Millionaire

A number of large investors have recently bought and sold shares of MYO. Hudson Bay Capital Management LP bought a new position in Myomo during the 4th quarter worth approximately $294,000. Sequoia Financial Advisors LLC bought a new position in Myomo during the 4th quarter worth approximately $257,000. Finally, Virtu Financial LLC bought a new position in Myomo during the 4th quarter worth approximately $124,000.

ILLEGAL ACTIVITY WARNING: “Myomo (MYO) PT Set at $12.00 by HC Wainwright” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.thecerbatgem.com/2018/03/12/myomo-myo-pt-set-at-12-00-by-hc-wainwright.html.

Myomo Company Profile

Myomo, Inc is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke.

Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.